Veterinary Medicine Information website

Enrocare 25 mg/ml Solution for Injection for Dogs, Cats, Rabbits, Rodents, Reptiles and Ornamental birds

Authorised
  • Enrofloxacin
Download as PDF

Product identification

Medicine name:
Enrocare 25 mg/ml Solution for Injection for Dogs, Cats, Rabbits, Rodents, Reptiles and Ornamental birds
Active substance:
  • Enrofloxacin
Target species:
  • Reptile
  • Ornamental bird
  • Dog
  • Cat
  • Rabbit
  • Chinchilla
  • Gerbil
  • Guinea pig
  • Hamster
  • Mouse
  • Rat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Enrofloxacin
    25.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Rabbit
      • Meat and offal
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • 100 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.100 ml vial sold in packs containing 12 x 100 ml cartons.
  • 100 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.100 ml vials sold in pack containing 6 x 100 ml cartons.
  • 100 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.100 ml vial sold in packs containing 1 x 100 ml cartons.
  • 50 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.50 ml vial sold in packs containing 12 x 50 ml cartons.
  • 50 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.50 ml vial sold in packs containing 6 x 50 ml cartons.
  • 50 ml Amber Type I multidose glass vial with a grey bromobutyl rubber stopper and aluminium overseal.50 ml vial sold in packs containing 1 x 50 ml cartons.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Emdoka
Marketing authorisation date:
Manufacturing sites for batch release:
  • Produlab Pharma B.V.
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 675/10/01/1025
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0455/001
Concerned member states:
  • France
  • Luxembourg
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download